SHORT REPORT |
Department of Mental Health Sciences, University College London (UCL) Medical School, Hampstead Campus and Camden and Islington NHS Foundation Trust, London
Camden and Islington NHS Foundation Trust, London
Department of Mental Health Sciences, UCL Medical School, Bloomsbury Campus and Camden and Islington NHS Foundation Trust, London
Department of Mental Health Sciences, UCL Medical School, Hampstead Campus, London
Department of Mental Health Sciences, UCL Medical School, Bloomsbury Campus and Camden and Islington NHS Foundation Trust, London
Centre for Outcomes Research and Effectiveness, UCL, Torrington Place, London
Department of Mental Health Sciences, University College London (UCL) Medical School, Hampstead Campus and Camden and Islington NHS Foundation Trust, London, UK
Correspondence: Helen Killaspy, Department of Mental Health Sciences, UCL Medical School, Hampstead Campus, London NW3 2PF, UK. Email: h.killaspy{at}medsch.ucl.ac.uk
The only randomised controlled trial to test high-fidelity assertive community treatment (ACT) in the UK (the Randomised Evaluation of Assertive Community Treatment (REACT) study) found no advantage over usual care from community mental health teams in reducing the need for in-patient care and in other clinical outcomes, but participants found ACT more acceptable and engaged better with it. One possible reason for the lack of efficacy of ACT might be the short period of follow-up (18 months in the REACT study). This paper reports on participants service contact, in-patient service use and adverse events 36 months after randomisation.
Related articles in BJP:
This article has been cited by other articles:
![]() |
T. Burns End of the road for treatment-as-usual studies? The British Journal of Psychiatry, July 1, 2009; 195(1): 5 - 6. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters